首页 | 本学科首页   官方微博 | 高级检索  
     

艾司西酞普兰与西酞普兰治疗首发老年抑郁症的临床研究
引用本文:贾金鼎,杨建章,余学,程粉,张明松. 艾司西酞普兰与西酞普兰治疗首发老年抑郁症的临床研究[J]. 中国民康医学, 2011, 23(17): 2112-2113,2116. DOI: 10.3969/j.issn.1672-0369.2011.17.006
作者姓名:贾金鼎  杨建章  余学  程粉  张明松
作者单位:驻马店市精神病医院,河南驻马店,463000
摘    要:目的:比较艾司西酞普兰与西酞普兰治疗首发老年抑郁症的有效性和安全性。方法:将68例首发老年抑郁症患者随机分为A组(艾司西酞普兰)和B组(西酞普兰),疗程6周。用汉密尔顿抑郁量表(HAMD17)、临床总体印象量表(CGI)与不良反应量表(TESS)在治疗前和治疗后第1、2、4、6周末评定疗效与不良反应。结果:A组第1、4、6周末HAMD17与CGI评分均低于B组,两组有显著性差异(t=2.18,2.77,3.2,P<0.05或P<0.01);两组临床疗效有显著性差异(x2=4.19,P<0.05);两组不良反应差异无统计学意义(x2=0.15,P>0.05)。结论:艾司西肽普兰具有良好的抗抑郁效果,比西酞普兰起效更快、症状缓解更明显、疗效更好,而且安全性高,耐受性好,可作为老年抑郁症的一线用药。

关 键 词:老年抑郁症  艾司西酞普兰  西酞普兰

Clinical Study on Efficacy and Safety of Escit-alopram VS Citalopram in the Treatment of First-episode Geriatric Depression
JIA Jin-ding,YANG Jian-zhang,YU Xue,et al. Clinical Study on Efficacy and Safety of Escit-alopram VS Citalopram in the Treatment of First-episode Geriatric Depression[J]. medical journal of chinese peoples health, 2011, 23(17): 2112-2113,2116. DOI: 10.3969/j.issn.1672-0369.2011.17.006
Authors:JIA Jin-ding  YANG Jian-zhang  YU Xue  et al
Affiliation:JIA Jin-ding,YANG Jian-zhang,YU Xue,et al(Zhumadian mental hospital,Henan 463000,China)
Abstract:Objective:To compare the efficacy and safety of Escit-alopram and Citalopram in the treatment of first-episode geriatric depression.Methods:68 patients with first-episode geriatric depression were randomly divided into group A(Escit-alopram) and group B(Citalopram) for 6 weeks' treatment.Hamilton Depression rating scale(HAMD 17),Clinical Global Impression Scale(CGI) and Treatment Emergent symptom scale(TESS) were used to assess the efficacy and side effects respectively before treatment and after treatment ...
Keywords:Geriatric Depression  Escit-alopram  Citalopram  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号